Shanghai INT Medical Instruments Co (1501.HK) Stock Price
Shanghai INT Medical Instruments Co Price
Over the last 9 years Shanghai INT Medical Instruments Co grew revenue by 31.2% annually, reaching 1.22 B CNY. Earnings per share have grown at 23.9% per year over the last 9 years. For Shanghai INT Medical Instruments Co, the net margin of 20.8% is down versus 30.8% a few years ago. At today's price the dividend yield works out to roughly 1.08%. The payout ratio is around 24% of earnings. The dividend has grown at 11.4% per year over the past 4 years. The consensus 12-month price target for Shanghai INT Medical Instruments Co is 29.39 CNY, about 6.2% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Shanghai INT Medical Instruments Co stock price
Shanghai INT Medical Instruments Co business model & stock analysis
Frequently asked questions about Shanghai INT Medical Instruments Co
Analysts currently set an average price target of 29.39 CNY for the Shanghai INT Medical Instruments Co stock (median: 29.39 CNY), implying +6.2 % versus the latest price. The consensus is based on 7 analyst ratings.
Shanghai INT Medical Instruments Co Analyst Price Targets 2026
7 analysts currently rate the Shanghai INT Medical Instruments Co stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Shanghai INT Medical Instruments Co to generate revenue of 1.29 B CNY and earnings per share of 1.78 CNY.
Shanghai INT Medical Instruments Co Analyst Price Targets 2026
Converted at the current exchange rate, the Shanghai INT Medical Instruments Co share trades at 3.68 EUR (27.67 CNY).
The Shanghai INT Medical Instruments Co share (1501.HK) is listed on 1 stock exchanges, including: Hongkong (HKEX) (1501.HK).
The expected revenue of Shanghai INT Medical Instruments Co is 1.29 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Shanghai INT Medical Instruments Co is 308.52 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Shanghai INT Medical Instruments Co is currently 15.58. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shanghai INT Medical Instruments Co stock.
The price-to-sales ratio (P/S) of Shanghai INT Medical Instruments Co is currently 3.73. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shanghai INT Medical Instruments Co stock.
The Eulerpool Quality Score for Shanghai INT Medical Instruments Co is 5/10.
The ISIN of Shanghai INT Medical Instruments Co is CNE100003NH7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Shanghai INT Medical Instruments Co is 1501.HK. The ticker symbol is used to trade Shanghai INT Medical Instruments Co shares on the stock exchange.
Shanghai INT Medical Instruments Co stock
Shanghai INT Medical Instruments Co Peer Group
Shanghai INT Medical Instruments Co Ticker
Shanghai INT Medical Instruments Co FIGI
All fundamentals and in-depth analysis of Shanghai INT Medical Instruments Co
Our stock analysis for Shanghai INT Medical Instruments Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai INT Medical Instruments Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.